Skip to main content
See every side of every news story
Published • loading... • Updated

What's Behind Grail Stock's Wild Ride in 2026, and What Can Investors Expect in 2027?

Summary by BizToc
Grail (NASDAQ:GRAL) stock has been highly volatile in 2026, and that trend looks set to continue next year as well. Management expects its multi-cancer early detection (MCED) test, Galleri, to be approved in the first quarter of 2027, but that's only part of the story. Here's what investors need…

2 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Left
100% Left

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Sunday, November 22, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal